000			01787nam a22002057a 4500
001			D0001J000260
003			DOH
005			20210322102422.0
008			210322b ||||| |||| 00| 0 eng d
245	0	0	_aIvermectin, ‘wonder drug’ from Japan : _bthe human use perspective / _cAndy Crump and Satoshi Ōmura
520	3		_aDiscovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world’s most devastating and disfiguring diseases which have plagued the world’s poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin’s passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a “wonder” drug.
580			_aProc. Jpn. Acad., Ser. 2011 87 (2) pages 13-28
650		2	_aIvermectin
650		2	_aElephantiasis, Filarial _xdrug therapy
650		2	_aDrug Resistance
700	1		_aCrump, Andy
700	1		_aŌmura, Satoshi
856			_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/pdf/pjab-87-013.pdf
942			_cJA
999			_c3710 _d3710